Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000893220-08-000956
Filing Date
2008-03-31
Accepted
2008-03-31 16:00:12
Documents
15
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K PHARMANET DEVELOPMENT GROUP, INC. w51014e10vk.htm 10-K 891683
2 SEVERANCE AGREEMENT AND GENERAL RELEASE BY AND BETWEEN THE COMPANY AND DAVID NAT w51014exv10w40.htm EX-10.40 27915
3 ROBIN SHELDRICK EMPLOYMENT AGREEMENT w51014exv10w41.htm EX-10.41 79534
4 AMENDED AND RESTATED 1999 STOCK PLAN w51014exv10w42.htm EX-10.42 62788
5 CODE OF ETHICS w51014exv10w43.htm EX-10.43 43334
6 FORM OF EQUITY AGREEMENTS - AUGUST 2007 w51014exv10w44.htm EX-10.44 579587
7 AMENDED AND RESTATED 2004 EMPLOYEE STOCK PURCHASE PLAN w51014exv10w45.htm EX-10.45 27737
8 SIXTH AMENDMENT TO THE AMENDED AND RESTATED CREDIT AGREEMENT w51014exv10w46.htm EX-10.46 34756
9 SUBSIDIARIES OF PHARMANET DEVELOPMENT GROUP, INC. w51014exv21.htm EX-21 3623
10 CONSENT OF GRANT THORNTON LLP DATED MARCH 31, 2008 w51014exv23w1.htm EX-23.1 1879
11 CERTIFICATION OF CHIEF EXECUTIVE OFFICER (SECTION 302) w51014exv31w1.htm EX-31.1 5920
12 CERTIFICATION OF CHIEF FINANCIAL OFFICER (SECTION 302) w51014exv31w2.htm EX-31.2 5976
13 CERTIFICATION OF CHIEF EXECUTIVE OFFICER (SECTION 1350) w51014exv32w1.htm EX-32.1 3079
14 CERTIFICATION OF CHIEF FINANCIAL OFFICER (SECTION 1350) w51014exv32w2.htm EX-32.2 3137
15 GRAPHIC w51014w5101401.gif GRAPHIC 10261
  Complete submission text file 0000893220-08-000956.txt   1786767
Mailing Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242
Business Address 504 CARNEGIE CENTER PRINCETON NJ 08540-6242 609-951-6800
PharmaNet Development Group Inc (Filer) CIK: 0001089542 (see all company filings)

EIN.: 592407464 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16119 | Film No.: 08724611
SIC: 8731 Services-Commercial Physical & Biological Research